FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,349,000 | +19.8% | 14,837 | -47.3% | 0.00% | +33.3% |
| Q3 2020 | $1,126,000 | -1.1% | 28,163 | -15.1% | 0.00% | -25.0% |
| Q2 2020 | $1,138,000 | -8.5% | 33,166 | -40.8% | 0.00% | +33.3% |
| Q1 2020 | $1,244,000 | +32.5% | 56,000 | +16.7% | 0.00% | 0.0% |
| Q4 2019 | $939,000 | +51.2% | 48,000 | +20.0% | 0.00% | +50.0% |
| Q3 2019 | $621,000 | +205.9% | 40,000 | +300.0% | 0.00% | +100.0% |
| Q2 2019 | $203,000 | +13.4% | 10,000 | -9.1% | 0.00% | 0.0% |
| Q3 2018 | $179,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |